StockData
Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc. (DCOY) income statement

DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.83−0.04 (-4.68%)

Close on Nov 20, 2026Market cap $543.41KP/E –Yield –

See a number that looks wrong?